SCHEMBL5607055

SCHEMBL5607055

Cn1sc(-c2ccccc2)c(Nc2ccc(N3CCOCC3)nc2)c1=O

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 8/20 0.48
CYP1A2 P05177 2/20 0.46
RAB9A P51151 3/20 0.44
NPC1 O15118 2/20 0.44
LMNA P02545 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
GAA P10253 2/20 0.43
MAPT P10636 2/20 0.43
CYP2C19 P33261 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
KDM4E B2RXH2 2/20 0.41
HTT P42858 1/20 0.41
HSD17B10 Q99714 1/20 0.40
CNR2 P34972 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3487111 0.73 DGAT1 (0.47) DGAT1CYP1A2RAB9ANPC1LMNA
SCHEMBL5666285 0.72 KDM1A (0.47) CYP1A2RAB9ANPC1SMN1; SMN2GAA
SCHEMBL5607270 0.72 KDM1A (0.47) CYP1A2LMNASMN1; SMN2MAPTMEN1
SCHEMBL5613996 0.71 MAPT (0.46) CYP1A2RAB9ANPC1LMNASMN1; SMN2
SCHEMBL3487298 0.69 NR1H2 (0.62) DGAT1CYP1A2RAB9ANPC1LMNA
SCHEMBL4504400 0.69 RAB9A (0.52) DGAT1CYP1A2RAB9ANPC1LMNA
SCHEMBL16773016 0.68 CNR2 (0.69) DGAT1CYP1A2LMNASMN1; SMN2GAA
SCHEMBL2790485 0.68 MAPT (0.58) DGAT1CYP1A2RAB9ANPC1LMNA
SCHEMBL13229247 0.67 DGAT1 (0.63) DGAT1CYP1A2RAB9ANPC1LMNA
SCHEMBL4822517 0.67 DGAT1 (0.46) DGAT1CYP1A2RAB9ANPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1838686-A1 DERIVATIVES OF ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDES AS LIVER X RECEPTOR MODULATORS AstraZeneca AB (SE) 2007-10-03 EP disclosed
WO-2006073363-A1 DERIVATIVES OF ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDES AS LIVER X RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2006-07-13 WO disclosed